New twist on sleeve gastrectomy aims to cut complications
NCT ID NCT06271317
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new version of sleeve gastrectomy (a weight loss surgery) that adds a Nissen fundoplication to reduce acid reflux. Researchers will compare 30-day complication rates between the new technique and standard sleeve gastrectomy in 100 adults with obesity. The goal is to see if the new approach is safer in the short term.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nissen sleeve gastrectomy (surgical procedure)
What this could lead to
If successful, this could show that the Nissen sleeve technique is as safe as standard sleeve gastrectomy, offering an option that may reduce acid reflux after surgery.
What could go wrong
This is a small, early-stage study (100 participants) comparing two surgical techniques. It only looks at complications within 30 days, so long-term safety and effectiveness are not yet known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Nantes
RECRUITINGNantes, Nantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact